These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 38482279)

  • 1. Adverse events following immunization of ChAdOx1 nCoV-19 vaccine among healthcare workers of a medicine-teaching institution of North India.
    Jha A; Kumar P; Goel SK; Bharatwal AA; Dhamnetiya D; Singh S; Jha RP
    J Family Med Prim Care; 2024 Jan; 13(1):298-310. PubMed ID: 38482279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and determinants of adverse events following ChAdOx1 nCoV-19 vaccination (COVISHIELD) - A retrospective cohort study among healthcare workers in central Karnataka, India.
    Davalagi SB; Nayak VP; Ghose A; Marakatti SS; Kasturi ES; Maganahalli AS
    J Family Med Prim Care; 2023 Nov; 12(11):2869-2874. PubMed ID: 38186765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adverse events following ChAdOx1 nCoV-19 Vaccine (COVISHIELD) amongst health care workers: A prospective observational study.
    Kamal D; Thakur V; Nath N; Malhotra T; Gupta A; Batlish R
    Med J Armed Forces India; 2021 Jul; 77(Suppl 2):S283-S288. PubMed ID: 34334895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adverse events following the first dose of Covishield (ChAdOx1 nCoV-19) vaccination among health workers in selected districts of central and western Nepal: A cross-sectional study.
    Subedi P; Yadav GK; Paudel B; Regmi A; Pyakurel P
    PLoS One; 2021; 16(12):e0260638. PubMed ID: 34932553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adverse events following immunisation (AEFI) of COVISHIELD vaccination among healthcare workers in Ghana.
    Marfoh K; Samba A; Okyere E; Acheampong F; Owusu E; Darko DNA; Zakariah J; Mensa H; Aidoo E; Mohammed Y
    BMJ Open; 2023 Jun; 13(6):e061643. PubMed ID: 37380201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surveillance on Adverse Events Following COVISHIELD (ChAdOx1 nCoV-19) vaccination in Goa, India: An Observational Study.
    Jose D; Dhupdale N; Cacodcar JA; Kamat U
    Curr Drug Saf; 2023; 18(4):516-527. PubMed ID: 35927820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adverse events following immunization with ChAdOx1 nCoV-19 and BBIBP-CorV vaccine: A comparative study among healthcare professionals of Nepal.
    Rayamajhi S; Rafi MA; Tripathi N; Dongol AS; Pandey M; Rayamajhi S; Bhandari S; Shrestha P; Hasan MT; Hossain MG
    PLoS One; 2022; 17(8):e0272729. PubMed ID: 35947626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence, Pattern and Severity of Adverse Events Following Immunization (AEFIs) Associated With Chadox1 nCOV-19 Corona Virus Vaccine (Recombinant) Among the Healthcare Workers of a Tertiary Care Institute of Eastern Uttar Pradesh, India.
    Kamble B; Bashar MA; Mishra CP
    Cureus; 2022 Feb; 14(2):e21848. PubMed ID: 35273834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Active Symptom-Based Surveillance of Adverse Events Following Immunization Among Individuals Vaccinated with ChAdOx1 nCoV-19 Coronavirus Vaccine in a Tertiary Hospital of Kerala.
    Jose M; Rajmohan P; Thomas J; Krishna S; Antony B; Gopinathan UU; Iyyapan EM; Porinchu RM; Jose P; Raphael L; Kuttichira P
    Curr Drug Saf; 2022; 17(4):327-334. PubMed ID: 35135453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors influencing adverse events following immunization with AZD1222 in Vietnamese adults during first half of 2021.
    Tran VN; Nguyen HA; Le TTA; Truong TT; Nguyen PT; Nguyen TTH
    Vaccine; 2021 Oct; 39(44):6485-6491. PubMed ID: 34607748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adverse Events Following COVISHIELD and VERO CELL Vaccination Campaigns Against COVID-19.
    Adhikari S; Maharjan J; Bhattarai S; Kunwar K; Agrawal S; Dangal RK; Chapagain RH; Bista TB; Bhattarai S
    J Nepal Health Res Counc; 2024 Mar; 21(4):651-658. PubMed ID: 38616598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors influencing adverse events following COVID-19 vaccination.
    Villanueva P; McDonald E; Croda J; Croda MG; Dalcolmo M; Dos Santos G; Jardim B; Lacerda M; Lynn DJ; Marshall H; Oliveira RD; Rocha J; Sawka A; Val F; Pittet LF; Messina NL; Curtis N
    Hum Vaccin Immunother; 2024 Dec; 20(1):2323853. PubMed ID: 38445666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ADR Profile of the Covishield Vaccine Among Healthcare Workers in a Tertiary Care Teaching Hospital in India.
    Deb T; Garg R; Kaur M; Beniwal A; Gupta V
    Curr Drug Saf; 2022; 17(4):344-349. PubMed ID: 35049437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety, immunogenecity and effectiveness of ChAdOx1 nCoV-19 vaccine during the second wave of pandemic in India: a real-world study.
    Chavan P; Dey R; Castelino R; Kamble A; Poladia P; Bagal R; Jadhav M; Shirsat A; Chavan A; Dhumal S; Kumar S; Krishnamurty MN; Bhat V; Bhattacharjee A; Gota V
    Drug Metab Pers Ther; 2023 Sep; 38(3):227-236. PubMed ID: 37098129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence of Early Adverse Events Following Covishield (ChAdOx1 nCoV-19) Vaccination: A Prospective Study.
    Velhal GD; Kamath YV; Agrawal AS; Vora DS; Dwivedi VR
    Indian J Community Med; 2022; 47(4):613-617. PubMed ID: 36742958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. More Than Three-Fourths of AstraZeneca (ChAdox1 COV-19) COVID-19 Vaccinated Individuals Develop Post Immunization Adverse Event in Northwest Ethiopia.
    Muluneh AG; Merid MW; Gelaye KA; Tilahun SY; Teshager NW; Abereha AY; Sugamo KS; Yimer MA; Kassa GM
    Infect Drug Resist; 2022; 15():2409-2416. PubMed ID: 35535029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adverse events following introduction of the ChAdOx1 nCoV-19 vaccine in Somalia in 2021: findings from a fragile setting and implications for the future.
    Hamayoun M; Abdulrazak I; Farid M; Malik MR; Mohamud MF
    IJID Reg; 2022 Sep; 4():47-52. PubMed ID: 35720961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adverse events following immunisation of COVID-19 vaccine among health care workers in the first phase of vaccination.
    Rahmat H; Leelavathi M; Wan Ismail WF
    Med J Malaysia; 2022 Nov; 77(6):637-642. PubMed ID: 36448378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ChAdOx1 nCoV-19 Vaccine Side Effects among Healthcare Workers in Trinidad and Tobago.
    Gopaul CD; Ventour D; Thomas D
    Vaccines (Basel); 2022 Mar; 10(3):. PubMed ID: 35335098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determinants of associated events following AZD1222 (Covishield) vaccination in a high-risk population in Nepal.
    Poudel KM; Shah N; Prakash M; Deo SK; Bhandari S; Poudel TR
    BMC Infect Dis; 2022 May; 22(1):422. PubMed ID: 35505278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.